Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

NCT02131077 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Tennis Elbow

Interventions

BIOLOGICAL: ALLO-ASC-TI
DRUG: Placebo

Sponsor

Anterogen Co., Ltd.